TRVI
Trevi Therapeutics Inc
14.40$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +475.0% | +69.6% | +20.5% | +6.4% | -14.0% | +186.0% | +19.5% | -2.0% | |
| – | +144,266.2% | +142.0% | +127.2% | +114.5% | +5.2% | -8.5% | -3.4% | +59.7% | +44.5% | |
| – | +1,273.6% | +38.5% | -51.0% | +80.8% | +16.9% | -17.9% | – | – | – | |
| – | – | -178.7% | – | -32.9% | +42.6% | -181.6% | – | – | -151.1% | |
| – | +0.0% | +1,115.4% | -94.3% | +255.6% | +396.9% | +0.0% | -13.8% | -74.5% | -65.7% | |
| – | +0.0% | +1,115.4% | -94.3% | +255.6% | +335,440.6% | +0.0% | – | -136.2% | +337.1% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | -105.1% | -20.9% | -72.7% | – | – | – | – | – | |
| – | -196.0% | -41.7% | – | +0.0% | -141.7% | +0.4% | +62.4% | -98.7% | -91.3% | |
| – | +152.7% | -100.0% | +2,017,342.8% | -77.2% | +24.3% | +435.8% | -107.1% | – | +96.8% | |
| – | – | -207.9% | – | -124.6% | – | – | – | -91.4% | -993.1% | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.